help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Carli, M.
Right arrow Articles by del Prete, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Carli, M.
Right arrow Articles by del Prete, G.

Journal of Clinical Endocrinology & Metabolism, Vol 77, 1120-1124, Copyright © 1993 by Endocrine Society


ARTICLES

Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy

M de Carli, MM D'Elios, S Mariotti, C Marcocci, A Pinchera, M Ricci, S Romagnani and G del Prete
Division of Clinical Immunology and Allergology, Institute of Clinica Medica 3, University of Florence, Italy.

Lymphocytic infiltration of muscular and connective tissues of the retroorbital (RO) space is a histological hallmark of Graves' ophthalmopathy (GO). We have characterized some phenotypical and functional features of T cells derived from RO infiltrates of four GO patients who were submitted to orbital decompression. Fragments of RO tissue were cultured for 7 days in IL-2-conditioned medium in order to generate T cell lines of in vivo activated T cells. Phenotypical analysis of freshly isolated peripheral blood (PB) lymphocytes both from patients and four healthy controls showed a predominance of CD4+ T cells (CD4/CD8 ratios 1.9:2.5), whereas RO-derived T cell lines displayed almost equal proportions of CD4+ and CD8+ cells (CD4/CD8 ratios 0.9:1.2). RO T cell lines and PB T cells from patients and controls were then cloned using a high-efficiency cloning procedure. The phenotypical and functional features of 153 T cell clones (TCC) derived from RO infiltrates were examined and compared with those of 166 and 236 TCC derived from the PB of patients and controls, respectively. CD4/CD8 ratios ranged from 0.8-1.4 in the series of RO- derived TCC and from 1.9-2.2 in the corresponding series of PB-derived TCC. Assessment of lectin-dependent cytolytic activity showed similar proportions of cytotoxic clones in TCC derived from the PB of patients (37%) and controls (38%); most of the cytolytic TCC was CD8+. In contrast, the proportion of cytolytic RO TCC was markedly higher (106/153 = 69%), including 100% of CD8+ and the majority (59/79 = 75%) of CD4+ clones. When compared to TCC derived from the PB of both patients and controls, RO TCC showed remarkably high proportions of both CD8+ and CD4+ clones with a Th1-like cytokine profile, as documented by their ability to secrete IL-2, IFN-gamma, and tumor necrosis factor-alpha (TNF-alpha), but not IL-4 or IL-5. This study provides evidence that cytolytic T cells with Th1 profile of cytokine production predominate in RO infiltrates of GO, a pattern quite similar to those previously described in thyroid infiltrates of Hashimoto's thyroiditis or Graves' disease. The peculiar cytokine secretion profile of RO T cells may be of importance in the pathogenesis of both the tissue alterations and fibrogenic process observed in GO.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
M. Rotondi, L. Chiovato, S. Romagnani, M. Serio, and P. Romagnani
Role of Chemokines in Endocrine Autoimmune Diseases
Endocr. Rev., August 1, 2007; 28(5): 492 - 520.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Antonelli, M. Rotondi, S. M. Ferrari, P. Fallahi, P. Romagnani, S. S. Franceschini, M. Serio, and E. Ferrannini
Interferon-{gamma}-Inducible {alpha}-Chemokine CXCL10 Involvement in Graves' Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-{gamma} Agonists
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 614 - 620.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Han and T. J. Smith
T Helper Type 1 and Type 2 Cytokines Exert Divergent Influence on the Induction of Prostaglandin E2 and Hyaluronan Synthesis by Interleukin-1{beta} in Orbital Fibroblasts: Implications for the Pathogenesis of Thyroid-Associated Ophthalmopathy
Endocrinology, January 1, 2006; 147(1): 13 - 19.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. E. Feldon, D. J. J. Park, C. W. O'Loughlin, V. T. Nguyen, S. Landskroner-Eiger, D. Chang, T. H. Thatcher, and R. P. Phipps
Autologous T-Lymphocytes Stimulate Proliferation of Orbital Fibroblasts Derived from Patients with Graves' Ophthalmopathy
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 3913 - 3921.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Chen, S. Tsui, and T. J. Smith
IL-1{beta} Induces IL-6 Expression in Human Orbital Fibroblasts: Identification of an Anatomic-Site Specific Phenotypic Attribute Relevant to Thyroid-Associated Ophthalmopathy
J. Immunol., July 15, 2005; 175(2): 1310 - 1319.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Han and T. J. Smith
Induction by IL-1{beta} of Tissue Inhibitor of Metalloproteinase-1 in Human Orbital Fibroblasts: Modulation of Gene Promoter Activity by IL-4 and IFN-{gamma}
J. Immunol., March 1, 2005; 174(5): 3072 - 3079.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
A K Eckstein, B Quadbeck, S Tews, K Mann, C Kruger, C H Mohr, K-P Steuhl, J Esser, and R K Gieseler
Thyroid associated ophthalmopathy: evidence for CD4+ {gamma}{delta} T cells; de novo differentiation of RFD7+ macrophages, but not of RFD1+ dendritic cells; and loss of {gamma}{delta} and {alpha}{beta} T cell receptor expression
Br. J. Ophthalmol., June 1, 2004; 88(6): 803 - 808.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. S. Prabhakar, R. S. Bahn, and T. J. Smith
Current Perspective on the Pathogenesis of Graves' Disease and Ophthalmopathy
Endocr. Rev., December 1, 2003; 24(6): 802 - 835.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Kumar and R. S. Bahn
Relative Overexpression of Macrophage-Derived Cytokines in Orbital Adipose Tissue from Patients with Graves' Ophthalmopathy
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4246 - 4250.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Pritchard, R. Han, N. Horst, W. W. Cruikshank, and T. J. Smith
Immunoglobulin Activation of T Cell Chemoattractant Expression in Fibroblasts from Patients with Graves' Disease Is Mediated Through the Insulin-Like Growth Factor I Receptor Pathway
J. Immunol., June 15, 2003; 170(12): 6348 - 6354.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. S. Bahn
Pathophysiology of Graves' Ophthalmopathy: The Cycle of Disease
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 1939 - 1946.
[Full Text] [PDF]


Home page
Int ImmunolHome page
D. Sewell, Z. Qing, E. Reinke, D. Elliot, J. Weinstock, M. Sandor, and Z. Fabry
Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization
Int. Immunol., January 1, 2003; 15(1): 59 - 69.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Pritchard, N. Horst, W. Cruikshank, and T. J. Smith
Igs from Patients with Graves' Disease Induce the Expression of T Cell Chemoattractants in Their Fibroblasts
J. Immunol., January 15, 2002; 168(2): 942 - 950.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. Bartalena, A. Pinchera, and C. Marcocci
Management of Graves' Ophthalmopathy: Reality and Perspectives
Endocr. Rev., April 1, 2000; 21(2): 168 - 199.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
D. Sciaky, W. Brazer, D. M. Center, W. W. Cruikshank, and T. J. Smith
Cultured Human Fibroblasts Express Constitutive IL-16 mRNA: Cytokine Induction of Active IL-16 Protein Synthesis Through a Caspase-3-Dependent Mechanism
J. Immunol., April 1, 2000; 164(7): 3806 - 3814.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Hiromatsu, D. Yang, T. Bednarczuk, I. Miyake, K. Nonaka, and Y. Inoue
Cytokine Profiles in Eye Muscle Tissue and Orbital Fat Tissue from Patients with Thyroid-Associated Ophthalmopathy
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1194 - 1199.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. P. Aniszewski, R. W. Valyasevi, and R. S. Bahn
Relationship between Disease Duration and Predominant Orbital T Cell Subset in Graves' Ophthalmopathy
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 776 - 780.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. J. Cao and T. J. Smith
Leukoregulin upregulation of prostaglandin endoperoxide H synthase-2 expression in human orbital fibroblasts
Am J Physiol Cell Physiol, December 1, 1999; 277(6): C1075 - C1085.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. J. Smith and S. J. Parikh
HMC-1 Mast Cells Activate Human Orbital Fibroblasts in Coculture: Evidence for Up-Regulation of Prostaglandin E2 and Hyaluronan Synthesis
Endocrinology, August 1, 1999; 140(8): 3518 - 3525.
[Abstract] [Full Text]


Home page
J. Exp. Med.Home page
J. T. Chang, E. M. Shevach, and B. M. Segal
Regulation of Interleukin (IL)-12 Receptor beta 2 Subunit Expression by Endogenous IL-12: A Critical Step in the Differentiation of Pathogenic Autoreactive T Cells
J. Exp. Med., March 15, 1999; 189(6): 969 - 978.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. J. Cao, H.-S. Wang, Y. Zhang, H.-Y. Lin, R. P. Phipps, and T. J. Smith
Activation of Human Orbital Fibroblasts through CD40 Engagement Results in a Dramatic Induction of Hyaluronan Synthesis and Prostaglandin Endoperoxide H Synthase-2 Expression. INSIGHTS INTO POTENTIAL PATHOGENIC MECHANISMS OF THYROID-ASSOCIATED OPHTHALMOPATHY
J. Biol. Chem., November 6, 1998; 273(45): 29615 - 29625.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. A. Young, C. H. Evans, and T. J. Smith
Leukoregulin induction of protein expression in human orbital fibroblasts: Evidence for anatomical site-restricted cytokine-target cell interactions
PNAS, July 21, 1998; 95(15): 8904 - 8909.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
G. D. Sempowski, J. Rozenblit, T. J. Smith, and R. P. Phipps
Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production
Am J Physiol Cell Physiol, March 1, 1998; 274(3): C707 - C714.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
B. M. Segal, B. K. Dwyer, and E. M. Shevach
An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease
J. Exp. Med., February 16, 1998; 187(4): 537 - 546.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-S. Wang, H. J. Cao, V. D. Winn, L. J. Rezanka, Y. Frobert, C. H. Evans, D. Sciaky, D. A. Young, and T. J. Smith
Leukoregulin Induction of Prostaglandin-Endoperoxide H Synthase-2 in Human Orbital Fibroblasts. AN IN VITRO MODEL FOR CONNECTIVE TISSUE INFLAMMATION
J. Biol. Chem., September 13, 1996; 271(37): 22718 - 22728.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society